Human medicines European public assessment report (EPAR): Yuflyma, adalimumab, Date of authorisation: 11/02/2021, Revision: 18, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 27 March 2025 - 16:00

Human medicines European public assessment report (EPAR): Yuflyma, adalimumab, Date of authorisation: 11/02/2021, Revision: 18, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/yuflyma

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters